Cargando…
Inhibiting CDK6 Activity by Quercetin Is an Attractive Strategy for Cancer Therapy
[Image: see text] Cyclin-dependent kinase 6 (CDK6) is a potential drug target that plays an important role in the progression of different types of cancers. We performed in silico and in vitro screening of different natural compounds and found that quercetin has a high binding affinity for the CDK6...
Autores principales: | Yousuf, Mohd, Khan, Parvez, Shamsi, Anas, Shahbaaz, Mohd, Hasan, Gulam Mustafa, Haque, Qazi Mohd Rizwanul, Christoffels, Alan, Islam, Asimul, Hassan, Md. Imtaiyaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594119/ https://www.ncbi.nlm.nih.gov/pubmed/33134711 http://dx.doi.org/10.1021/acsomega.0c03975 |
Ejemplares similares
-
Ellagic Acid Controls Cell Proliferation and Induces Apoptosis in Breast Cancer Cells via Inhibition of Cyclin-Dependent Kinase 6
por: Yousuf, Mohd, et al.
Publicado: (2020) -
Effect of pH on the structure and function of cyclin-dependent kinase 6
por: Yousuf, Mohd, et al.
Publicado: (2022) -
Rosmarinic Acid Exhibits Anticancer Effects via MARK4 Inhibition
por: Anwar, Saleha, et al.
Publicado: (2020) -
Inhibiting Cyclin-Dependent
Kinase 6 by Taurine: Implications
in Anticancer Therapeutics
por: Yousuf, Mohd, et al.
Publicado: (2022) -
Insights into the Antibacterial Activity of Prolactin-Inducible Protein against the Standard and Environmental MDR Bacterial Strains
por: Yousuf, Mohd, et al.
Publicado: (2022)